Evidence map›Paper›PMID 37519556›Full record

ArticleCureus2023

Hydroxychloroquine-Induced Myopathy Responding to Intravenous Immunoglobulin (IVIG).

Hani Almoallim, Alaa Samkari, Ahmad Fallata, Heba Adam, Malak Kary, Mohammed Bahabri, Mohamed Cheikh

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Hani AlmoallimDepartment of Medicine, Faculty of Medicine, Umm Al-Qura University, Makkah, SAU.
Alaa SamkariDepartment of Medicine, Faculty of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Ahmad FallataDepartment of Medicine, Faculty of Medicine, University of Tabuk, Tabuk, SAU.
Heba AdamDepartment of Medicine, Faculty of Medicine, Dr. Soliman Fakeeh Hospital, Jeddah, SAU.
Malak KaryDepartment of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, SAU.
Mohammed BahabriDepartment of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, SAU.
Mohamed CheikhDepartment of Medicine, Faculty of Medicine, Dr. Soliman Fakeeh Hospital, Jeddah, SAU.
King Abdullah International Medical Research Center · SAKing Saud bin Abdulaziz University for Health Sciences · SAKing Abdulaziz University · SANational Guard Health Affairs · SAUmm al-Qura University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydroxychloroquine (HCQ), a drug used to treat many diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), has limited reports documenting drug-induced myopathies as a side effect. This entity is underdiagnosed with unclear treatment interventions apart from discontinuing the offending drug. We report a case of a biopsy-proven hydroxychloroquine-induced myopathy in a 35-year-old female patient with SLE. The offending drug was stopped, but the patient did not improve. However, she showed marked improvement after the use of intravenous immunoglobulin (IVIG).

Indexed as

hydroxychloroquinehydroxychloroquine-induced myopathyivigmyopathysystemic lupus erythematosus

Identifiers

PMID37519556
PMCPMC10372520
OpenAlexW4382461284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.